|
KR20210029756A
|
|
Inspection method and apparatus for sound direction discrimination ability
|
|
KR20200144537A
|
|
A pharmaceutical composition for preventing or treating nervous system diseases
|
|
KR20200144538A
|
|
A pharmaceutical composition for preventing or treating neurological diseases comprising zinc and NAC
|
|
KR102224059B1
|
|
Anticancer drug containing RhoA peptide inhibitor as an active ingredient
|
|
KR102215336B1
|
|
Anti-Viral composition with extract of Rhododendron brachycarpum
|
|
KR20200111625A
|
|
A vaccine against influenza A viruses
|
|
KR102214913B1
|
|
Methods for biomechanical analysis of muscular systems contributing to the proximal joint kidney of human fingers
|
|
KR102214912B1
|
|
Biomechanical analysis device of proximal joint of the human finger
|
|
KR102179418B1
|
|
Method and apparatus for measuring dna droplet concentration
|
|
KR102180865B1
|
|
Photocurable bioink with electroconductivity and a preparation thereof
|
|
KR102179032B1
|
|
Biomarkers for Distinguishing GCI and TBI
|
|
KR20210021186A
|
|
A pharmaceutical composition containing cell-transducing CNRIP1 fusion protein for preventing or treating neuronal disorder
|
|
KR20210019616A
|
|
System, apparatus, program and server for treating of sexual dysfunction
|
|
KR20210018655A
|
|
A pharmaceutical composition containing cell-transducing p27 fusion protein for preventing or treating neuronal disorder
|
|
KR102136147B1
|
|
System, apparatus, method and program for transmitting and receiving power and data considering residual power via superframe
|
|
KR102136146B1
|
|
System, apparatus, method and program for transmitting and receiving power and data using composite structure superframe
|
|
KR20210018620A
|
|
A pharmaceutical composition containing cell-transducing endophilin-A1 fusion protein for preventing and treating neuronal disorder
|
|
KR102168304B1
|
|
Prediction method for Successful liberation or 28-Day Mortality by Measuring NOX4 Concentration in Artificial Respiratory Intubation Patients
|
|
KR102136148B1
|
|
System, apparatus, method and program for setting start time of notification contention access period of superframe
|
|
KR20210018590A
|
|
Pharmaceutical composition for treating cerebral ischemia containing p27 fusion protein
|
